--- title: Allergan Aesthetics Enters Into Option to Acquire Cypris Medical, a LaunchPad Alumni Company description: LaunchPad Alumni, Cypris Medical, enters into option with Allergan Aesthetics image: https://blog.octaneoc.org/hubfs/11-LaunchpadPresentations-917.jpg --- [![Octane](https://blog.octaneoc.org/hubfs/Octane_December2019/Images/Octane.svg)](https://octaneoc.org/) - [Accelerate](https://octaneoc.org/launchpad/) - [LaunchPad SBDC Accelerator](https://octaneoc.org/launchpad/) - [Pitch Presentation Template](https://octaneoc.org/launchpad/#template) - [Our Alumni](https://octaneoc.org/launchpad-alumni/) - [Apply](https://info.octaneoc.org/launchpadapply) - [Grow](https://octaneoc.org/octane-enterprise-solutions/) - [Events](https://octaneoc.org/events-programs/) - [Aesthetics Tech Forum](https://octaneoc.org/aesthetic-technology-summit/) - [Tech Innovation Forum](https://octaneoc.org/tech-innovation-forum/) - [Ophthalmology Tech Forum](https://octaneoc.org/ophthalmology-technology-summit/) - [High Tech Awards](https://octaneoc.org/high-tech-awards/) - [Cardiovascular Tech Summit](https://octaneoc.org/cardiovascular-tech-summit/) - [Medical Innovation Forum](https://octaneoc.org/medtech-innovation-forum/) - [Programs & Calendar](https://octaneoc.org/events-programs/#calendar) - [Partner](https://octaneoc.org/partner/) - [Partner with Us](https://octaneoc.org/partner/) - [Octane Partners](https://octaneoc.org/octane-partners/) - [Become a Member](http://register.octaneoc.org/membership) - [Mission](https://octaneoc.org/mission/) - [What We Do](https://octaneoc.org/mission/) - [Community Initiatives](https://octaneoc.org/octane-foundation-for-innovation/) - [Women Leaders of Octane](https://octaneoc.org/octane-foundation-for-innovation/#women-leaders) - [Non-Profit Accelerator](https://octaneoc.org/octane-foundation-for-innovation/#npa) - [LaunchPad Accelerator](https://octaneoc.org/octane-foundation-for-innovation/#launchpad) - [STEAM Ahead](https://octaneoc.org/octane-foundation-for-innovation/#stem-fellows) - [Next Wave](https://octaneoc.org/octane-foundation-for-innovation/#orange-movement) - [Team](https://octaneoc.org/mission/#team) - [Board & Advisors](https://octaneoc.org/board-advisors/) - [Careers](https://octaneoc.org/careers/) - [News & Blog](https://blog.octaneoc.org/) Latest [Events](https://blog.octaneoc.org/topic/events) [Med Tech](https://blog.octaneoc.org/topic/med-tech) [Tech](https://blog.octaneoc.org/topic/tech) [Innovation](https://blog.octaneoc.org/topic/innovation) [Octane News](https://blog.octaneoc.org/topic/octane-news) ## [Winners Announced - The 2022 High Tech Awards](https://blog.octaneoc.org/hta-2022-winners) by [Natalie Matsumoto](https://blog.octaneoc.org/author/natalie-matsumoto) on September 29, 2022 [Read more](https://blog.octaneoc.org/hta-2022-winners) - CATEGORIES ### Subscribe to Email Updates [Success Story](https://blog.octaneoc.org/topic/success-story) [Medical Aesthetics](https://blog.octaneoc.org/topic/medical-aesthetics) | 4 min read # Allergan Aesthetics Enters Into Option to Acquire Cypris Medical, a LaunchPad Alumni Company Written by [PRnewswire.com](https://blog.octaneoc.org/author/prnewswire.com) - - - Post from [PRNewswire.com](https://www.prnewswire.com/news-releases/allergan-aesthetics-enters-into-option-to-acquire-cypris-medical-301206886.html?tc=eml_cleartime) IRVINE, Calif., Jan. 12, 2021 /PRNewswire/ -- Today Allergan Aesthetics, an AbbVie company (NYSE: [ABBV](https://www.prnewswire.com/news-releases/allergan-aesthetics-enters-into-option-to-acquire-cypris-medical-301206886.html?tc=eml_cleartime#financial-modal)), announced that it has entered into a warrant agreement with Cypris Medical, a privately held, medical device company based in Chicago. Following the completion of a clinical trial to be initiated in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company's Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating midface descent as well as for neck lifts. Replacing the scalpel, Xact is designed to allow for lifting and suturing of the superficial muscular aponeurotic system (SMAS), the same tissue mobilized in a facelift, but in a minimally-invasive manner. The innovative technology intends to provide patients surgery-like results in the office with little to no downtime. "As a global leader in aesthetics, we are proud to support the research of an innovative device that complements our iconic portfolio of non-invasive treatment options like Botox Cosmetic and our Juvéderm Collection of Fillers," says Carrie Strom, SVP AbbVie and President, Global Allergan Aesthetics. "We know there is continued unmet need for minimally-invasive procedures for midface descent, and Xact affords us the ability to create a new alternative for our customers so they can continue to offer leading-edge treatments to patients."   "As the market leader in facial aesthetics, Allergan Aesthetics is the ideal partner to lead the advancement and continued development of Xact," says Dan Holton, President and CEO, Cypris Medical. "We share the same vision with respect to product safety, efficacy and data-driven innovation which allow us to offer plastic surgeons and patients new options for aesthetic medicine." **About Allergan Aesthetics** At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit [www.AllerganAesthetics.com](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=1535805749&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D2679085716%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D3779445843%2526u%253Dhttp%25253A%25252F%25252Fwww.allerganaesthetics.com%25252F%2526a%253Dwww.AllerganAesthetics.com%26a%3Dwww.AllerganAesthetics.com&a=www.AllerganAesthetics.com). **About AbbVie** AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at [www.abbvie.com](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=453353648&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D3325340885%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D4193731623%2526u%253Dhttp%25253A%25252F%25252Fwww.abbvie.com%25252F%2526a%253Dwww.abbvie.com%26a%3Dwww.abbvie.com&a=www.abbvie.com). Follow @abbvie on [Twitter](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=821139240&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D3208594722%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D1100655542%2526u%253Dhttps%25253A%25252F%25252Fnam04.safelinks.protection.outlook.com%25252F%25253Furl%25253Dhttps%2525253A%2525252F%2525252Ftwitter.com%2525252Fabbvie%252526data%25253D01%2525257C01%2525257CKate.Mcshane%25252540allergan.com%2525257C7014b8fad01440bbe45308d7fdb35cad%2525257C4b79823aaef849faa34cb4ba59e8afd9%2525257C0%252526sdata%25253Dl0wKNxVWzZW1yEAI%2525252Fz4GD7GNoTKC8eB4tVIYvkxTF3k%2525253D%252526reserved%25253D0%2526a%253DTwitter%26a%3DTwitter&a=Twitter), [Facebook](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=2828584997&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D974486287%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D2307337232%2526u%253Dhttps%25253A%25252F%25252Fnam04.safelinks.protection.outlook.com%25252F%25253Furl%25253Dhttps%2525253A%2525252F%2525252Fwww.facebook.com%2525252FAbbVieGlobal%2525252F%252526data%25253D01%2525257C01%2525257CKate.Mcshane%25252540allergan.com%2525257C7014b8fad01440bbe45308d7fdb35cad%2525257C4b79823aaef849faa34cb4ba59e8afd9%2525257C0%252526sdata%25253D9qnZ0seWKFZXO%2525252BaMc%2525252B5w%2525252F9SmnNdkKbSIJUkzv7fJSEU%2525253D%252526reserved%25253D0%2526a%253DFacebook%26a%3DFacebook&a=Facebook), [Instagram](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=2141849034&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D3156438573%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D2194964310%2526u%253Dhttps%25253A%25252F%25252Fnam04.safelinks.protection.outlook.com%25252F%25253Furl%25253Dhttps%2525253A%2525252F%2525252Fwww.instagram.com%2525252Fabbvie%2525252F%252526data%25253D01%2525257C01%2525257CKate.Mcshane%25252540allergan.com%2525257C7014b8fad01440bbe45308d7fdb35cad%2525257C4b79823aaef849faa34cb4ba59e8afd9%2525257C0%252526sdata%25253DngizaUoPENshdWMj%2525252BrsOUlc%2525252FP3E1T%2525252FQufo%2525252BPyhBv6uQ%2525253D%252526reserved%25253D0%2526a%253DInstagram%26a%3DInstagram&a=Instagram), [YouTube](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=2829919461&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D3460551922%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2817241-1%2526h%253D827179412%2526u%253Dhttps%25253A%25252F%25252Fnam04.safelinks.protection.outlook.com%25252F%25253Furl%25253Dhttps%2525253A%2525252F%2525252Fwww.youtube.com%2525252Fuser%2525252FAbbVie%252526data%25253D01%2525257C01%2525257CKate.Mcshane%25252540allergan.com%2525257C7014b8fad01440bbe45308d7fdb35cad%2525257C4b79823aaef849faa34cb4ba59e8afd9%2525257C0%252526sdata%25253D%2525252FrtDKWBk%2525252FiGfh%2525252FK%2525252B5%2525252BrwS68jXyY1sgSwHlLwiD2J%2525252BK8%2525253D%252526reserved%25253D0%2526a%253DYouTube%26a%3DYouTube&a=YouTube) and [LinkedIn](https://c212.net/c/link/?t=0&l=en&o=3034776-1&h=1026346018&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2830442-1%26h%3D767889386%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fabbvie%252F%26a%3DLinkedIn&a=LinkedIn). Read the full press release [here](https://www.prnewswire.com/news-releases/allergan-aesthetics-enters-into-option-to-acquire-cypris-medical-301206886.html?tc=eml_cleartime) ### Related Categories [Success Story](https://blog.octaneoc.org/tag/success-story) [Medical Aesthetics](https://blog.octaneoc.org/tag/medical-aesthetics) ### [PRnewswire.com](https://blog.octaneoc.org/author/prnewswire.com) Popular [Start Up](https://blog.octaneoc.org/topic/start-up) [Business Resource](https://blog.octaneoc.org/topic/business-resource) ## [Why Brand Strategy Is So Important For Startups](https://blog.octaneoc.org/why-brand-strategy-is-so-important-for-startups) [Read more](https://blog.octaneoc.org/why-brand-strategy-is-so-important-for-startups) Popular [Business Resource](https://blog.octaneoc.org/topic/business-resource) ## [The Importance of a Human Capital Management Strategy](https://blog.octaneoc.org/the-importance-of-a-human-capital-management-strategy) [Read more](https://blog.octaneoc.org/the-importance-of-a-human-capital-management-strategy) Popular [Orange County](https://blog.octaneoc.org/topic/orange-county) ## [City of Hope: Advancing World-Renowned Cancer Treatment and Research in Orange County](https://blog.octaneoc.org/city-of-hope-advancing-world-renowned-cancer-treatment-and-research-in-orange-county) [Read more](https://blog.octaneoc.org/city-of-hope-advancing-world-renowned-cancer-treatment-and-research-in-orange-county) ## Accelerate Your Capital Funding Strategy LaunchPad is a Top-5 SBDC in the nation, offering pro-bono expertise help you prepare to raise capital.  [Apply to LaunchPad SBDC](https://info.octaneoc.org/launchpadapply) ### Let Us Know What You Thought about this Post. Put your Comment Below. ### You may also like: [Orange County](https://blog.octaneoc.org/topic/orange-county) [Innovation](https://blog.octaneoc.org/topic/innovation) [Octane News](https://blog.octaneoc.org/topic/octane-news) [Success Story](https://blog.octaneoc.org/topic/success-story) [Women Leaders](https://blog.octaneoc.org/topic/women-leaders) [Women On Boards](https://blog.octaneoc.org/topic/women-on-boards) ## [WISE(R) podcast - Women Leaders of Octane](https://blog.octaneoc.org/wisepodcast) In a recent podcast with WISE (Women Investing In Security and Education) Linda DiMario with the Octane Foundation for I... [Orange County](https://blog.octaneoc.org/topic/orange-county) [Octane News](https://blog.octaneoc.org/topic/octane-news) [Success Story](https://blog.octaneoc.org/topic/success-story) ## [UCI Celebrates 20 Years of Octane OC Building an Entrepreneurial Innovation Ecosystem](https://blog.octaneoc.org/uci-celebrates-20-years-of-octane-oc-building-an-entrepreneurial-innovation-ecosystem) Graphic credit: Evans Akanno, UCI Beall Applied Innovation [Med Tech](https://blog.octaneoc.org/topic/med-tech) [Success Story](https://blog.octaneoc.org/topic/success-story) ## [LaunchPad Alumni, Cooler Heads Receives FDA Clearance To Help Save Cancer Patients' Hair](https://blog.octaneoc.org/launchpad-alumni-cooler-heads-receives-fda-clearance-to-help-save-cancer-patients-hair) Read the full press release from prnewswire.com here ## **Contact Us.**   i[nfo@octaneoc.org](mailto:info@octaneoc.org) 949.330.6564 [Get In Touch](https://octanestaging1.wpengine.com/) © 2020 Octane - - - - - Search for: - [Incubator](https://octaneoc.org/incubator/) - [LaunchPad Accelerator](https://octaneoc.org/launchpad/) - [Growth & Consulting Services](https://octaneoc.org/grow/) - [Events & Programs](https://octaneoc.org/events-programs/) - [Partners](https://octaneoc.org/partner/) - [Our Mission](https://octaneoc.org/mission/) - [News & Blog](https://blog.octaneoc.org/) - [Privacy Policy](https://octaneoc.org/privacy/)